Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 CAD | +3.19% | -1.52% | +94.00% |
04-11 | BioRem Shares Jump 29% as its Fourth-Quarter Profit Triples | MT |
04-11 | BioRem Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2022 | 28.86M 21.08M | Sales 2023 | 25.17M 18.38M | Capitalization | 15.7M 11.46M |
---|---|---|---|---|---|
Net income 2022 | 1M 730K | Net income 2023 | 2M 1.46M | EV / Sales 2022 | 0.51 x |
Net Debt 2022 | 971K 709K | Net Debt 2023 | 1.89M 1.38M | EV / Sales 2023 | 0.7 x |
P/E ratio 2022 |
9.78
x | P/E ratio 2023 |
7.69
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.07% |
1 day | +3.19% | ||
1 week | -1.52% | ||
1 month | +30.20% | ||
3 months | +25.16% | ||
6 months | +128.24% | ||
Current year | +94.00% |
Managers | Title | Age | Since |
---|---|---|---|
Derek Webb
CEO | Chief Executive Officer | - | 95-12-31 |
Douglas Newman
DFI | Director of Finance/CFO | - | - |
Mark Smit
CTO | Chief Tech/Sci/R&D Officer | - | 08-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William White
CHM | Chairman | 72 | 20-06-21 |
Derek Webb
CEO | Chief Executive Officer | - | 95-12-31 |
Alex Gill
BRD | Director/Board Member | - | 20-06-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.94 | +3.19% | 31,469 |
24-05-02 | 1.88 | 0.00% | 34,600 |
24-05-01 | 1.88 | -3.09% | 16,809 |
24-04-30 | 1.94 | -0.51% | 56,714 |
24-04-29 | 1.95 | -1.02% | 23,015 |
Delayed Quote Toronto S.E., May 03, 2024 at 03:59 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+94.00% | 22.26M | |
+12.96% | 8.89B | |
+36.64% | 2.4B | |
-9.82% | 1.07B | |
+10.70% | 784M | |
+6.61% | 616M | |
-11.56% | 624M | |
+10.86% | 647M | |
-4.66% | 577M | |
+3.62% | 515M |
- Stock Market
- Equities
- BRM Stock